These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I trial, cervical microinjection, and final surgical safety outcomes. Riley J, Glass J, Feldman EL, Polak M, Bordeau J, Federici T, Johe K, Boulis NM. Neurosurgery; 2014 Jan 26; 74(1):77-87. PubMed ID: 24018694 [Abstract] [Full Text] [Related]
7. Intraspinal stem cell transplantation for amyotrophic lateral sclerosis. Chen KS, Sakowski SA, Feldman EL. Ann Neurol; 2016 Mar 26; 79(3):342-53. PubMed ID: 26696091 [Abstract] [Full Text] [Related]
8. Human glial-restricted progenitor transplantation into cervical spinal cord of the SOD1 mouse model of ALS. Lepore AC, O'Donnell J, Kim AS, Williams T, Tuteja A, Rao MS, Kelley LL, Campanelli JT, Maragakis NJ. PLoS One; 2011 Mar 26; 6(10):e25968. PubMed ID: 21998733 [Abstract] [Full Text] [Related]
9. Cervical multilevel intraspinal stem cell therapy: assessment of surgical risks in Gottingen minipigs. Raore B, Federici T, Taub J, Wu MC, Riley J, Franz CK, Kliem MA, Snyder B, Feldman EL, Johe K, Boulis NM. Spine (Phila Pa 1976); 2011 Feb 01; 36(3):E164-71. PubMed ID: 21099736 [Abstract] [Full Text] [Related]
10. Intraspinal administration of human spinal cord-derived neural progenitor cells in the G93A-SOD1 mouse model of ALS delays symptom progression, prolongs survival and increases expression of endogenous neurotrophic factors. Knippenberg S, Rath KJ, Böselt S, Thau-Habermann N, Schwarz SC, Dengler R, Wegner F, Petri S. J Tissue Eng Regen Med; 2017 Mar 01; 11(3):751-764. PubMed ID: 25641599 [Abstract] [Full Text] [Related]
11. Serial in vivo imaging of transplanted allogeneic neural stem cell survival in a mouse model of amyotrophic lateral sclerosis. Srivastava AK, Gross SK, Almad AA, Bulte CA, Maragakis NJ, Bulte JWM. Exp Neurol; 2017 Mar 01; 289():96-102. PubMed ID: 28038988 [Abstract] [Full Text] [Related]
12. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Karussis D, Karageorgiou C, Vaknin-Dembinsky A, Gowda-Kurkalli B, Gomori JM, Kassis I, Bulte JW, Petrou P, Ben-Hur T, Abramsky O, Slavin S. Arch Neurol; 2010 Oct 01; 67(10):1187-94. PubMed ID: 20937945 [Abstract] [Full Text] [Related]
13. Intraspinal stem cell transplantation for amyotrophic lateral sclerosis: Ready for efficacy clinical trials? Atassi N, Beghi E, Blanquer M, Boulis NM, Cantello R, Caponnetto C, Chiò A, Dunnett SB, Feldman EL, Vescovi A, Mazzini L, attendees of the International Workshop on Progress in Stem Cells Research for ALS/MND. Cytotherapy; 2016 Dec 01; 18(12):1471-1475. PubMed ID: 27720637 [Abstract] [Full Text] [Related]
14. Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials. Petrou P, Gothelf Y, Argov Z, Gotkine M, Levy YS, Kassis I, Vaknin-Dembinsky A, Ben-Hur T, Offen D, Abramsky O, Melamed E, Karussis D. JAMA Neurol; 2016 Mar 01; 73(3):337-44. PubMed ID: 26751635 [Abstract] [Full Text] [Related]
15. Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis. Oh KW, Moon C, Kim HY, Oh SI, Park J, Lee JH, Chang IY, Kim KS, Kim SH. Stem Cells Transl Med; 2015 Jun 01; 4(6):590-7. PubMed ID: 25934946 [Abstract] [Full Text] [Related]